Australian Meningococcal Surveillance Programme, 1 April to 30 June 2017

The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and by non-culture based techniques. Data contained in quar­terly reports are restricted to a description of the number of cases of IMD by jurisdiction and serogroup, where known. A full analysis of laboratory confirmed cases of IMD in each calen­dar year is contained in the AMSP annual reports.

Page last updated: 14 December 2017

Monica M Lahra and Rodney Enriquez

The reference laboratories of the National Neisseria Network, Australia report laboratory data on invasive meningococcal disease (IMD) cases confirmed by laboratory testing using culture and non-culture based techniques for the Australian Meningococcal Surveillance Programme (AMSP).

Culture positive cases, where Neisseria meningitidis is grown from a normally sterile site or skin lesions, and non-culture based diagnoses, derived from results of nucleic acid amplification testing (NAAT) and serological techniques, are defined as IMD according to Public Health Laboratory Network definitions.

Data contained in quarterly reports are restricted to a description of the numbers of cases by jurisdiction and serogroup, where known. Some minor corrections to data in the Table may be made in subsequent reports if additional data are received.

A full analysis of laboratory confirmed cases of IMD in each calendar year is contained in the AMSP annual report published in CDI.

Table: Number of laboratory confirmed cases of invasive meningococcal disease by jurisdiction and serogroup, Australia, second quarter 2017.

Jurisdiction

Year

Serogroup

A

B

C

Y

W

ND/other

All

Q2

ytd

Q2

ytd

Q2

ytd

Q2

ytd

Q2

ytd

Q2

ytd

Q2

ytd

Australian Capital Territory

2017

0

0

0

0

0

0

0

0

0

0

0

0

0

0

2016

0

0

0

0

0

0

0

0

0

0

0

0

0

0

New South Wales

2017

0

0

7

16

1

3

1

3

3

5

2

2

14

29

2016

0

0

5

10

0

1

4

4

5

9

0

3

14

27

Northern Territory

2017

0

0

0

0

0

0

0

1

0

1

0

0

0

2

2016

0

0

1

1

0

0

0

0

0

0

0

0

1

1

Queensland

2017

0

0

4

14

0

0

2

11

4

6

0

1

10

32

2016

0

0

2

6

0

0

2

6

3

4

0

0

7

16

South Australia

2017

0

0

5

6

0

0

0

2

2

4

0

0

7

12

2016

0

0

5

11

0

0

0

0

0

1

0

0

5

12

Tasmania

17

0

0

2

2

0

0

0

0

1

5

0

0

3

7

16

0

0

0

0

0

0

0

0

0

2

0

0

0

2

Victoria

17

0

0

3

8

2

2

3

7

9

17

0

0

17

34

16

0

0

4

7

0

1

2

2

9

14

0

0

15

24

Western Australia

17

0

0

2

5

0

1

0

0

2

6

0

1

4

13

16

0

0

1

2

0

0

0

0

0

1

0

0

1

3

Australia

17

0

0

23

51

3

6

6

24

21

44

2

4

55

129

16

0

0

18

37

0

2

8

12

17

31

0

3

43

85

  1. Neisseria Reference Laboratory and World Health Organisation Collaborating Centre for STD, Sydney. Department of Microbiology, New South Wales Health Pathology, The Prince of Wales Hospital, Randwick, NSW Australia.
  2. School of Medical Sciences, Faculty of Medicine, The University of New South Wales, 2053 Australia for the National Neisseria Network, Australia.

In this section